speb/financial-data huggingface dataset:
CZFS balance_sheet (annual, 2023-12-31) — Accounts Receivable: 11043000.00
CZFS balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -17823000.00
CZFS balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 143233000.00
CZFS income_statement (annual, 2023-12-31) — Amortization: 373000.00
CZFS income_statement (annual, 2023-12-31) — Amortization Of Intangibles Income Statement: 373000.00
CZFS cash_flow (annual, 2023-12-31) — Amortization Of Securities: 1581000.00
CZFS balance_sheet (annual, 2023-12-31) — Available For Sale Securities: 1938000.00
CZFS income_statement (annual, 2023-12-31) — Basic Average Shares: 4470662.00
CZFS income_statement (annual, 2023-12-31) — Basic EPS: 3.98
CZFS cash_flow (annual, 2023-12-31) — Beginning Cash Position: 26211000.00
CZFS balance_sheet (annual, 2023-12-31) — Buildings And Improvements: 22948000.00
CZFS cash_flow (annual, 2023-12-31) — Capital Expenditure: -2617000.00
CZFS balance_sheet (annual, 2023-12-31) — Capital Stock: 5161000.00
CZFS balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 56888000.00
CZFS balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Federal Funds Sold: 56888000.00
CZFS cash_flow (annual, 2023-12-31) — Cash Dividends Paid: -8503000.00
CZFS cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: -59395000.00
CZFS cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: 59465000.00
CZFS cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Operating Activities: 26537000.00
CZFS cash_flow (annual, 2023-12-31) — Change In Account Payable: 2181000.00
CZFS cash_flow (annual, 2023-12-31) — Change In Payable: 2181000.00
CZFS cash_flow (annual, 2023-12-31) — Change In Payables And Accrued Expense: 2181000.00
CZFS cash_flow (annual, 2023-12-31) — Change In Receivables: -1485000.00
CZFS cash_flow (annual, 2023-12-31) — Change In Working Capital: 696000.00
CZFS cash_flow (annual, 2023-12-31) — Changes In Account Receivables: -1485000.00
CZFS cash_flow (annual, 2023-12-31) — Changes In Cash: 26607000.00
CZFS balance_sheet (annual, 2023-12-31) — Common Stock: 5161000.00
CZFS cash_flow (annual, 2023-12-31) — Common Stock Dividend Paid: -8503000.00
CZFS balance_sheet (annual, 2023-12-31) — Common Stock Equity: 279666000.00
CZFS cash_flow (annual, 2023-12-31) — Common Stock Issuance: 34000.00
CZFS cash_flow (annual, 2023-12-31) — Common Stock Payments: -265000.00
CZFS balance_sheet (annual, 2023-12-31) — Construction In Progress: 1921000.00
CZFS balance_sheet (annual, 2023-12-31) — Current Debt: 12572000.00
CZFS balance_sheet (annual, 2023-12-31) — Current Debt And Capital Lease Obligation: 12572000.00
CZFS cash_flow (annual, 2023-12-31) — Deferred Income Tax: 595000.00
CZFS cash_flow (annual, 2023-12-31) — Deferred Tax: 595000.00
CZFS cash_flow (annual, 2023-12-31) — Depreciation Amortization Depletion: 1520000.00
CZFS income_statement (annual, 2023-12-31) — Depreciation Amortization Depletion Income Statement: 373000.00
CZFS cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 1520000.00
CZFS income_statement (annual, 2023-12-31) — Depreciation And Amortization In Income Statement: 373000.00
CZFS balance_sheet (annual, 2023-12-31) — Derivative Product Liabilities: 7922000.00
CZFS income_statement (annual, 2023-12-31) — Diluted Average Shares: 4470662.00
CZFS income_statement (annual, 2023-12-31) — Diluted EPS: 3.98
CZFS income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: 17811000.00
CZFS cash_flow (annual, 2023-12-31) — End Cash Position: 52818000.00
CZFS cash_flow (annual, 2023-12-31) — Financing Cash Flow: -59395000.00
CZFS cash_flow (annual, 2023-12-31) — Free Cash Flow: 23920000.00
CZFS cash_flow (annual, 2023-12-31) — Gain Loss On Investment Securities: 195000.00
CZFS cash_flow (annual, 2023-12-31) — Gain Loss On Sale Of Business: 0.00
CZFS income_statement (annual, 2023-12-31) — Gain On Sale Of Business: 0.00
CZFS income_statement (annual, 2023-12-31) — Gain On Sale Of Security: -195000.00
CZFS balance_sheet (annual, 2023-12-31) — Gains Losses Not Affecting Retained Earnings: -24911000.00
CZFS income_statement (annual, 2023-12-31) — General And Administrative Expense: 36465000.00
CZFS balance_sheet (annual, 2023-12-31) — Goodwill: 85758000.00
CZFS balance_sheet (annual, 2023-12-31) — Goodwill And Other Intangible Assets: 89408000.00
CZFS balance_sheet (annual, 2023-12-31) — Gross PPE: 39207000.00
CZFS cash_flow (annual, 2023-12-31) — Income Tax Paid Supplemental Data: 5130000.00
CZFS income_statement (annual, 2023-12-31) — Insurance And Claims: 1475000.00
CZFS income_statement (annual, 2023-12-31) — Interest Expense: 46858000.00
CZFS income_statement (annual, 2023-12-31) — Interest Income: 125711000.00
CZFS cash_flow (annual, 2023-12-31) — Interest Paid Supplemental Data: 44677000.00
CZFS balance_sheet (annual, 2023-12-31) — Invested Capital: 563659000.00
CZFS cash_flow (annual, 2023-12-31) — Investing Cash Flow: 59465000.00
CZFS balance_sheet (annual, 2023-12-31) — Investments And Advances: 419539000.00
CZFS cash_flow (annual, 2023-12-31) — Issuance Of Capital Stock: 34000.00
CZFS cash_flow (annual, 2023-12-31) — Issuance Of Debt: 40000000.00
CZFS balance_sheet (annual, 2023-12-31) — Land And Improvements: 5839000.00
CZFS balance_sheet (annual, 2023-12-31) — Line Of Credit: 12572000.00
CZFS balance_sheet (annual, 2023-12-31) — Long Term Debt: 271421000.00
CZFS balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 271421000.00
CZFS cash_flow (annual, 2023-12-31) — Long Term Debt Issuance: 40000000.00
CZFS cash_flow (annual, 2023-12-31) — Long Term Debt Payments: 0.00
CZFS balance_sheet (annual, 2023-12-31) — Machinery Furniture Equipment: 8499000.00
CZFS cash_flow (annual, 2023-12-31) — Net Business Purchase And Sale: 3435000.00
CZFS cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: -231000.00
CZFS balance_sheet (annual, 2023-12-31) — Net Debt: 227105000.00
CZFS income_statement (annual, 2023-12-31) — Net Income: 17811000.00
CZFS income_statement (annual, 2023-12-31) — Net Income Common Stockholders: 17811000.00
CZFS income_statement (annual, 2023-12-31) — Net Income Continuous Operations: 17811000.00
CZFS income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: 17811000.00
CZFS income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: 17811000.00
CZFS cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: 17811000.00
CZFS income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: 17811000.00
CZFS income_statement (annual, 2023-12-31) — Net Interest Income: 78853000.00
CZFS cash_flow (annual, 2023-12-31) — Net Investment Purchase And Sale: 99180000.00
CZFS cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: 5431000.00
CZFS cash_flow (annual, 2023-12-31) — Net Long Term Debt Issuance: 40000000.00
CZFS cash_flow (annual, 2023-12-31) — Net Other Investing Changes: 1433000.00
CZFS balance_sheet (annual, 2023-12-31) — Net PPE: 21384000.00
CZFS cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: -2617000.00
CZFS cash_flow (annual, 2023-12-31) — Net Short Term Debt Issuance: -34569000.00
CZFS balance_sheet (annual, 2023-12-31) — Net Tangible Assets: 190258000.00
CZFS income_statement (annual, 2023-12-31) — Normalized Income: 25457925.00
CZFS income_statement (annual, 2023-12-31) — Occupancy And Equipment: 4945000.00
CZFS cash_flow (annual, 2023-12-31) — Operating Cash Flow: 26537000.00
CZFS cash_flow (annual, 2023-12-31) — Operating Gains Losses: -1257000.00
CZFS income_statement (annual, 2023-12-31) — Operating Revenue: 91865000.00
CZFS balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 4801604.00
CZFS balance_sheet (annual, 2023-12-31) — Other Equity Adjustments: -24911000.00
CZFS income_statement (annual, 2023-12-31) — Other Gand A: 1784000.00
CZFS balance_sheet (annual, 2023-12-31) — Other Intangible Assets: 3650000.00
CZFS cash_flow (annual, 2023-12-31) — Other Non Cash Items: -246000.00
CZFS income_statement (annual, 2023-12-31) — Other Non Interest Expense: 11748000.00
CZFS balance_sheet (annual, 2023-12-31) — Other Short Term Investments: 417601000.00
CZFS balance_sheet (annual, 2023-12-31) — Payables: 4298000.00
CZFS balance_sheet (annual, 2023-12-31) — Payables And Accrued Expenses: 4298000.00
CZFS balance_sheet (annual, 2023-12-31) — Preferred Stock: 0.00
CZFS income_statement (annual, 2023-12-31) — Pretax Income: 21575000.00
CZFS cash_flow (annual, 2023-12-31) — Proceeds From Stock Option Exercised: 0.00
CZFS income_statement (annual, 2023-12-31) — Professional Expense And Contract Services Expense: 1962000.00
CZFS cash_flow (annual, 2023-12-31) — Purchase Of Business: -1470000.00
CZFS cash_flow (annual, 2023-12-31) — Purchase Of Investment: -39373000.00
CZFS cash_flow (annual, 2023-12-31) — Purchase Of PPE: -2617000.00
CZFS balance_sheet (annual, 2023-12-31) — Receivables: 11043000.00
CZFS income_statement (annual, 2023-12-31) — Reconciled Depreciation: 1520000.00
CZFS cash_flow (annual, 2023-12-31) — Repayment Of Debt: 0.00
CZFS cash_flow (annual, 2023-12-31) — Repurchase Of Capital Stock: -265000.00
CZFS income_statement (annual, 2023-12-31) — Restructuring And Mergern Acquisition: 9269000.00
CZFS balance_sheet (annual, 2023-12-31) — Retained Earnings: 172975000.00
CZFS income_statement (annual, 2023-12-31) — Salaries And Wages: 34990000.00
CZFS cash_flow (annual, 2023-12-31) — Sale Of Business: 4905000.00
CZFS cash_flow (annual, 2023-12-31) — Sale Of Investment: 138553000.00
CZFS cash_flow (annual, 2023-12-31) — Sale Of PPE: 0.00
CZFS income_statement (annual, 2023-12-31) — Selling General And Administration: 36465000.00
CZFS balance_sheet (annual, 2023-12-31) — Share Issued: 5264484.00
CZFS income_statement (annual, 2023-12-31) — Special Income Charges: -9269000.00
CZFS cash_flow (annual, 2023-12-31) — Stock Based Compensation: 309000.00
CZFS balance_sheet (annual, 2023-12-31) — Stockholders Equity: 279666000.00
CZFS balance_sheet (annual, 2023-12-31) — Tangible Book Value: 190258000.00
CZFS income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: -1622075.00
CZFS income_statement (annual, 2023-12-31) — Tax Provision: 3764000.00
CZFS income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.18
CZFS balance_sheet (annual, 2023-12-31) — Total Assets: 2975321000.00
CZFS balance_sheet (annual, 2023-12-31) — Total Capitalization: 551087000.00
CZFS balance_sheet (annual, 2023-12-31) — Total Debt: 283993000.00
CZFS balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 279666000.00
CZFS balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 2695655000.00
CZFS income_statement (annual, 2023-12-31) — Total Unusual Items: -9269000.00
CZFS income_statement (annual, 2023-12-31) — Total Unusual Items Excluding Goodwill: -9269000.00
CZFS balance_sheet (annual, 2023-12-31) — Treasury Shares Number: 462880.00
CZFS balance_sheet (annual, 2023-12-31) — Treasury Stock: 16792000.00
CZFS cash_flow (quarterly, 2024-09-30) — Issuance Of Debt: 0.00
CZFS cash_flow (quarterly, 2024-09-30) — Long Term Debt Issuance: 0.00
CZFS cash_flow (quarterly, 2024-09-30) — Purchase Of Business: 0.00
CZFS income_statement (quarterly, 2024-09-30) — Restructuring And Mergern Acquisition: 0.00
CZFS income_statement (annual, 2024-12-31) — +Total Revenue: 100754000.00
CZFS balance_sheet (annual, 2024-12-31) — Accounts Payable: 4693000.00
CZFS balance_sheet (annual, 2024-12-31) — Accounts Receivable: 10307000.00
CZFS balance_sheet (annual, 2024-12-31) — Accumulated Depreciation: -18675000.00
CZFS balance_sheet (quarterly, 2024-12-31) — Accumulated Depreciation: -18675000.00
CZFS balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 144984000.00
CZFS income_statement (annual, 2024-12-31) — Amortization: 564000.00
CZFS income_statement (annual, 2024-12-31) — Amortization Of Intangibles Income Statement: 564000.00
CZFS cash_flow (annual, 2024-12-31) — Amortization Of Securities: 1372000.00
CZFS balance_sheet (annual, 2024-12-31) — Available For Sale Securities: 1747000.00
CZFS income_statement (annual, 2024-12-31) — Basic Average Shares: 4797686.00
CZFS income_statement (annual, 2024-12-31) — Basic EPS: 5.80
CZFS cash_flow (annual, 2024-12-31) — Beginning Cash Position: 52818000.00
CZFS balance_sheet (annual, 2024-12-31) — Buildings And Improvements: 23012000.00
CZFS balance_sheet (quarterly, 2024-12-31) — Buildings And Improvements: 23012000.00
CZFS cash_flow (annual, 2024-12-31) — Capital Expenditure: -1314000.00
CZFS balance_sheet (annual, 2024-12-31) — Capital Stock: 5208000.00
CZFS balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 46022000.00
CZFS balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Federal Funds Sold: 46022000.00
CZFS cash_flow (annual, 2024-12-31) — Cash Dividends Paid: -9302000.00
CZFS cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: 25275000.00
CZFS cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: -69073000.00
CZFS cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Operating Activities: 33182000.00
CZFS cash_flow (annual, 2024-12-31) — Change In Account Payable: 395000.00
CZFS cash_flow (annual, 2024-12-31) — Change In Payable: 395000.00
CZFS cash_flow (annual, 2024-12-31) — Change In Payables And Accrued Expense: 395000.00
CZFS cash_flow (annual, 2024-12-31) — Change In Receivables: 736000.00
CZFS cash_flow (annual, 2024-12-31) — Change In Working Capital: 1131000.00
CZFS cash_flow (annual, 2024-12-31) — Changes In Account Receivables: 736000.00
CZFS cash_flow (annual, 2024-12-31) — Changes In Cash: -10616000.00
CZFS balance_sheet (annual, 2024-12-31) — Common Stock: 5208000.00
CZFS cash_flow (annual, 2024-12-31) — Common Stock Dividend Paid: -9302000.00
CZFS balance_sheet (annual, 2024-12-31) — Common Stock Equity: 299734000.00
CZFS cash_flow (annual, 2024-12-31) — Common Stock Issuance: 0.00
CZFS cash_flow (quarterly, 2024-12-31) — Common Stock Issuance: 0.00
CZFS cash_flow (annual, 2024-12-31) — Common Stock Payments: -266000.00
CZFS balance_sheet (annual, 2024-12-31) — Construction In Progress: 2172000.00
CZFS balance_sheet (quarterly, 2024-12-31) — Construction In Progress: 2172000.00
CZFS balance_sheet (annual, 2024-12-31) — Current Debt: 7572000.00
CZFS balance_sheet (quarterly, 2024-12-31) — Current Debt: 7572000.00
CZFS balance_sheet (annual, 2024-12-31) — Current Debt And Capital Lease Obligation: 7572000.00
CZFS balance_sheet (quarterly, 2024-12-31) — Current Debt And Capital Lease Obligation: 7572000.00
CZFS cash_flow (annual, 2024-12-31) — Deferred Income Tax: 1771000.00
CZFS cash_flow (annual, 2024-12-31) — Deferred Tax: 1771000.00
CZFS cash_flow (annual, 2024-12-31) — Depreciation Amortization Depletion: 1806000.00
CZFS income_statement (annual, 2024-12-31) — Depreciation Amortization Depletion Income Statement: 564000.00
CZFS cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 1806000.00
CZFS income_statement (annual, 2024-12-31) — Depreciation And Amortization In Income Statement: 564000.00
CZFS balance_sheet (annual, 2024-12-31) — Derivative Product Liabilities: 5817000.00
CZFS income_statement (annual, 2024-12-31) — Diluted Average Shares: 4802616.00
CZFS income_statement (annual, 2024-12-31) — Diluted EPS: 5.79
CZFS income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: 27818000.00
CZFS cash_flow (annual, 2024-12-31) — End Cash Position: 42202000.00
CZFS cash_flow (annual, 2024-12-31) — Financing Cash Flow: 25275000.00
CZFS cash_flow (annual, 2024-12-31) — Free Cash Flow: 31868000.00
CZFS cash_flow (annual, 2024-12-31) — Gain Loss On Investment Securities: -145000.00
CZFS cash_flow (annual, 2024-12-31) — Gain Loss On Sale Of Business: -1102000.00
CZFS cash_flow (quarterly, 2024-12-31) — Gain Loss On Sale Of Business: 0.00
CZFS income_statement (annual, 2024-12-31) — Gain On Sale Of Business: 1102000.00
CZFS income_statement (quarterly, 2024-12-31) — Gain On Sale Of Business: 0.00
CZFS income_statement (annual, 2024-12-31) — Gain On Sale Of Security: 145000.00
CZFS balance_sheet (annual, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: -23521000.00
CZFS income_statement (annual, 2024-12-31) — General And Administrative Expense: 41343000.00
CZFS balance_sheet (annual, 2024-12-31) — Goodwill: 85758000.00
CZFS balance_sheet (annual, 2024-12-31) — Goodwill And Other Intangible Assets: 88650000.00
CZFS balance_sheet (annual, 2024-12-31) — Gross PPE: 40070000.00
CZFS balance_sheet (quarterly, 2024-12-31) — Gross PPE: 40070000.00
CZFS cash_flow (annual, 2024-12-31) — Income Tax Paid Supplemental Data: 2826000.00
CZFS income_statement (annual, 2024-12-31) — Insurance And Claims: 1996000.00
CZFS income_statement (annual, 2024-12-31) — Interest Expense: 67862000.00
CZFS income_statement (annual, 2024-12-31) — Interest Income: 152767000.00
CZFS cash_flow (annual, 2024-12-31) — Interest Paid Supplemental Data: 67466000.00
CZFS balance_sheet (annual, 2024-12-31) — Invested Capital: 580117000.00
CZFS cash_flow (annual, 2024-12-31) — Investing Cash Flow: -69073000.00
CZFS balance_sheet (annual, 2024-12-31) — Investments And Advances: 427659000.00
CZFS cash_flow (annual, 2024-12-31) — Issuance Of Capital Stock: 0.00
CZFS cash_flow (quarterly, 2024-12-31) — Issuance Of Capital Stock: 0.00
CZFS cash_flow (annual, 2024-12-31) — Issuance Of Debt: 0.00
CZFS cash_flow (quarterly, 2024-12-31) — Issuance Of Debt: 0.00
CZFS balance_sheet (annual, 2024-12-31) — Land And Improvements: 5839000.00
CZFS balance_sheet (quarterly, 2024-12-31) — Land And Improvements: 5839000.00
CZFS balance_sheet (annual, 2024-12-31) — Line Of Credit: 7572000.00
CZFS balance_sheet (quarterly, 2024-12-31) — Line Of Credit: 7572000.00
CZFS balance_sheet (annual, 2024-12-31) — Long Term Debt: 272811000.00
CZFS balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 272811000.00
CZFS cash_flow (annual, 2024-12-31) — Long Term Debt Issuance: 0.00
CZFS cash_flow (quarterly, 2024-12-31) — Long Term Debt Issuance: 0.00
CZFS cash_flow (annual, 2024-12-31) — Long Term Debt Payments: -35000000.00
CZFS cash_flow (quarterly, 2024-12-31) — Long Term Debt Payments: -25000000.00
CZFS balance_sheet (annual, 2024-12-31) — Machinery Furniture Equipment: 9047000.00
CZFS balance_sheet (quarterly, 2024-12-31) — Machinery Furniture Equipment: 9047000.00
CZFS cash_flow (annual, 2024-12-31) — Net Business Purchase And Sale: 7185000.00
CZFS cash_flow (quarterly, 2024-12-31) — Net Business Purchase And Sale: 0.00
CZFS cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: -266000.00
CZFS balance_sheet (annual, 2024-12-31) — Net Debt: 234361000.00
CZFS income_statement (annual, 2024-12-31) — Net Income: 27818000.00
CZFS income_statement (annual, 2024-12-31) — Net Income Common Stockholders: 27818000.00
CZFS income_statement (annual, 2024-12-31) — Net Income Continuous Operations: 27818000.00
CZFS income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: 27818000.00
CZFS income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: 27818000.00
CZFS cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: 27818000.00
CZFS income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: 27818000.00
CZFS income_statement (annual, 2024-12-31) — Net Interest Income: 84905000.00
CZFS cash_flow (annual, 2024-12-31) — Net Investment Purchase And Sale: -6757000.00
CZFS cash_flow (annual, 2024-12-31) — Net Issuance Payments Of Debt: -25721000.00
CZFS cash_flow (annual, 2024-12-31) — Net Long Term Debt Issuance: -35000000.00
CZFS cash_flow (quarterly, 2024-12-31) — Net Long Term Debt Issuance: -25000000.00
CZFS cash_flow (annual, 2024-12-31) — Net Other Investing Changes: 1808000.00
CZFS balance_sheet (annual, 2024-12-31) — Net PPE: 21395000.00
CZFS cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: -1314000.00
CZFS cash_flow (annual, 2024-12-31) — Net Short Term Debt Issuance: 9279000.00
CZFS balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 211084000.00
CZFS income_statement (annual, 2024-12-31) — Normalized Income: 26913258.00
CZFS income_statement (annual, 2024-12-31) — Occupancy And Equipment: 6051000.00
CZFS cash_flow (annual, 2024-12-31) — Operating Cash Flow: 33182000.00
CZFS cash_flow (annual, 2024-12-31) — Operating Gains Losses: -3563000.00
CZFS income_statement (annual, 2024-12-31) — Operating Revenue: 100754000.00
CZFS balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 4807208.00
CZFS balance_sheet (annual, 2024-12-31) — Other Equity Adjustments: -23521000.00
CZFS balance_sheet (annual, 2024-12-31) — Other Intangible Assets: 2892000.00
CZFS cash_flow (annual, 2024-12-31) — Other Non Cash Items: -152000.00
CZFS income_statement (annual, 2024-12-31) — Other Non Interest Expense: 14829000.00
CZFS balance_sheet (annual, 2024-12-31) — Other Short Term Investments: 425912000.00
CZFS balance_sheet (annual, 2024-12-31) — Payables: 4693000.00
CZFS balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 4693000.00
CZFS balance_sheet (annual, 2024-12-31) — Preferred Stock: 0.00
CZFS income_statement (annual, 2024-12-31) — Pretax Income: 33883000.00
CZFS cash_flow (annual, 2024-12-31) — Proceeds From Stock Option Exercised: 16000.00
CZFS income_statement (annual, 2024-12-31) — Professional Expense And Contract Services Expense: 2599000.00
CZFS cash_flow (annual, 2024-12-31) — Purchase Of Business: 0.00
CZFS cash_flow (quarterly, 2024-12-31) — Purchase Of Business: 0.00
CZFS cash_flow (annual, 2024-12-31) — Purchase Of Investment: -98022000.00
CZFS cash_flow (annual, 2024-12-31) — Purchase Of PPE: -1314000.00
CZFS balance_sheet (annual, 2024-12-31) — Receivables: 10307000.00
CZFS income_statement (annual, 2024-12-31) — Reconciled Depreciation: 1806000.00
CZFS cash_flow (annual, 2024-12-31) — Repayment Of Debt: -35000000.00
CZFS cash_flow (quarterly, 2024-12-31) — Repayment Of Debt: 56351000.00
CZFS cash_flow (annual, 2024-12-31) — Repurchase Of Capital Stock: -266000.00
CZFS income_statement (annual, 2024-12-31) — Restructuring And Mergern Acquisition: 0.00
CZFS income_statement (quarterly, 2024-12-31) — Restructuring And Mergern Acquisition: 0.00
CZFS balance_sheet (annual, 2024-12-31) — Retained Earnings: 189443000.00
CZFS income_statement (annual, 2024-12-31) — Salaries And Wages: 39347000.00
CZFS cash_flow (annual, 2024-12-31) — Sale Of Business: 7185000.00
CZFS cash_flow (quarterly, 2024-12-31) — Sale Of Business: 0.00
CZFS cash_flow (annual, 2024-12-31) — Sale Of Investment: 91265000.00
CZFS cash_flow (annual, 2024-12-31) — Sale Of PPE: 0.00
CZFS income_statement (annual, 2024-12-31) — Selling General And Administration: 41343000.00
CZFS balance_sheet (annual, 2024-12-31) — Share Issued: 5259652.00
CZFS income_statement (annual, 2024-12-31) — Special Income Charges: 1102000.00
CZFS income_statement (quarterly, 2024-12-31) — Special Income Charges: 0.00
CZFS cash_flow (annual, 2024-12-31) — Stock Based Compensation: 412000.00
CZFS balance_sheet (annual, 2024-12-31) — Stockholders Equity: 299734000.00
CZFS balance_sheet (annual, 2024-12-31) — Tangible Book Value: 211084000.00
CZFS income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: 197258.00
CZFS income_statement (annual, 2024-12-31) — Tax Provision: 6065000.00
CZFS income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.18
CZFS balance_sheet (annual, 2024-12-31) — Total Assets: 3025724000.00
CZFS balance_sheet (annual, 2024-12-31) — Total Capitalization: 572545000.00
CZFS balance_sheet (annual, 2024-12-31) — Total Debt: 280383000.00
CZFS balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 299734000.00
CZFS balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 2725990000.00
CZFS income_statement (annual, 2024-12-31) — Total Unusual Items: 1102000.00
CZFS income_statement (quarterly, 2024-12-31) — Total Unusual Items: 0.00
CZFS income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: 1102000.00
CZFS income_statement (quarterly, 2024-12-31) — Total Unusual Items Excluding Goodwill: 0.00
CZFS balance_sheet (annual, 2024-12-31) — Treasury Shares Number: 452444.00
CZFS balance_sheet (annual, 2024-12-31) — Treasury Stock: 16380000.00
CZFS income_statement (quarterly, 2025-03-31) — +Total Revenue: 26429000.00
CZFS balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 3143000.00
CZFS balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 10918000.00
CZFS balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 145010000.00
CZFS income_statement (quarterly, 2025-03-31) — Amortization: 127000.00
CZFS income_statement (quarterly, 2025-03-31) — Amortization Of Intangibles Income Statement: 127000.00
CZFS cash_flow (quarterly, 2025-03-31) — Amortization Of Securities: 217000.00
CZFS balance_sheet (quarterly, 2025-03-31) — Available For Sale Securities: 387637000.00
CZFS income_statement (quarterly, 2025-03-31) — Basic Average Shares: 4798043.00
CZFS income_statement (quarterly, 2025-03-31) — Basic EPS: 1.58
CZFS cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 42202000.00
CZFS cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -585000.00
CZFS balance_sheet (quarterly, 2025-03-31) — Capital Stock: 5208000.00
CZFS balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 40606000.00
CZFS balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Federal Funds Sold: 40606000.00
CZFS cash_flow (quarterly, 2025-03-31) — Cash Dividends Paid: -2355000.00
CZFS cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: -15633000.00
CZFS cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: -728000.00
CZFS cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: 10945000.00
CZFS cash_flow (quarterly, 2025-03-31) — Change In Account Payable: -1550000.00
CZFS cash_flow (quarterly, 2025-03-31) — Change In Payable: -1550000.00
CZFS cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: -1550000.00
CZFS cash_flow (quarterly, 2025-03-31) — Change In Receivables: -612000.00
CZFS cash_flow (quarterly, 2025-03-31) — Change In Working Capital: -2162000.00
CZFS cash_flow (quarterly, 2025-03-31) — Changes In Account Receivables: -612000.00
CZFS cash_flow (quarterly, 2025-03-31) — Changes In Cash: -5416000.00
CZFS balance_sheet (quarterly, 2025-03-31) — Common Stock: 5208000.00
CZFS cash_flow (quarterly, 2025-03-31) — Common Stock Dividend Paid: -2355000.00
CZFS balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 308296000.00
CZFS cash_flow (quarterly, 2025-03-31) — Common Stock Payments: -57000.00
CZFS cash_flow (quarterly, 2025-03-31) — Deferred Income Tax: -109000.00
CZFS cash_flow (quarterly, 2025-03-31) — Deferred Tax: -109000.00
CZFS cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 449000.00
CZFS income_statement (quarterly, 2025-03-31) — Depreciation Amortization Depletion Income Statement: 127000.00
CZFS cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 449000.00
CZFS income_statement (quarterly, 2025-03-31) — Depreciation And Amortization In Income Statement: 127000.00
CZFS balance_sheet (quarterly, 2025-03-31) — Derivative Product Liabilities: 5196000.00
CZFS income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 4799462.00
CZFS income_statement (quarterly, 2025-03-31) — Diluted EPS: 1.58
CZFS income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 7621000.00
CZFS cash_flow (quarterly, 2025-03-31) — End Cash Position: 36786000.00
CZFS cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: -15633000.00
CZFS cash_flow (quarterly, 2025-03-31) — Free Cash Flow: 10360000.00
CZFS cash_flow (quarterly, 2025-03-31) — Gain Loss On Investment Securities: 11000.00
CZFS cash_flow (quarterly, 2025-03-31) — Gain Loss On Sale Of Business: 0.00
CZFS income_statement (quarterly, 2025-03-31) — Gain On Sale Of Business: 0.00
CZFS income_statement (quarterly, 2025-03-31) — Gain On Sale Of Security: -11000.00
CZFS balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: -20239000.00
CZFS income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 10739000.00
CZFS balance_sheet (quarterly, 2025-03-31) — Goodwill: 85758000.00
CZFS balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 88465000.00
CZFS cash_flow (quarterly, 2025-03-31) — Income Tax Paid Supplemental Data: 0.00
CZFS income_statement (quarterly, 2025-03-31) — Insurance And Claims: 450000.00
CZFS income_statement (quarterly, 2025-03-31) — Interest Expense: 16012000.00
CZFS income_statement (quarterly, 2025-03-31) — Interest Income: 38585000.00
CZFS cash_flow (quarterly, 2025-03-31) — Interest Paid Supplemental Data: 17562000.00
CZFS balance_sheet (quarterly, 2025-03-31) — Invested Capital: 610323000.00
CZFS cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: -728000.00
CZFS balance_sheet (quarterly, 2025-03-31) — Investments And Advances: 432438000.00
CZFS balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 302027000.00
CZFS balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 302027000.00
CZFS cash_flow (quarterly, 2025-03-31) — Long Term Debt Payments: 0.00
CZFS cash_flow (quarterly, 2025-03-31) — Net Business Purchase And Sale: 0.00
CZFS cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: -57000.00
CZFS balance_sheet (quarterly, 2025-03-31) — Net Debt: 261421000.00
CZFS income_statement (quarterly, 2025-03-31) — Net Income: 7621000.00
CZFS income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 7621000.00
CZFS income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 7621000.00
CZFS income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 7621000.00
CZFS income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 7621000.00
CZFS cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: 7621000.00
CZFS income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 7621000.00
CZFS income_statement (quarterly, 2025-03-31) — Net Interest Income: 22573000.00
CZFS cash_flow (quarterly, 2025-03-31) — Net Investment Purchase And Sale: 1062000.00
CZFS cash_flow (quarterly, 2025-03-31) — Net Issuance Payments Of Debt: 3938000.00
CZFS cash_flow (quarterly, 2025-03-31) — Net Long Term Debt Issuance: 0.00
CZFS cash_flow (quarterly, 2025-03-31) — Net Other Investing Changes: 169000.00
CZFS balance_sheet (quarterly, 2025-03-31) — Net PPE: 21627000.00
CZFS cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: -573000.00
CZFS cash_flow (quarterly, 2025-03-31) — Net Short Term Debt Issuance: 3938000.00
CZFS balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 219831000.00
CZFS income_statement (quarterly, 2025-03-31) — Normalized Income: 7621000.00
CZFS income_statement (quarterly, 2025-03-31) — Occupancy And Equipment: 1621000.00
CZFS cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: 10945000.00
CZFS cash_flow (quarterly, 2025-03-31) — Operating Gains Losses: -261000.00
CZFS income_statement (quarterly, 2025-03-31) — Operating Revenue: 26429000.00
CZFS balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 4807268.00
CZFS balance_sheet (quarterly, 2025-03-31) — Other Equity Adjustments: -20239000.00
CZFS balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 2707000.00
CZFS cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: 4565000.00
CZFS income_statement (quarterly, 2025-03-31) — Other Non Interest Expense: 3374000.00
CZFS balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 44801000.00
CZFS balance_sheet (quarterly, 2025-03-31) — Payables: 3143000.00
CZFS balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 3143000.00
CZFS balance_sheet (quarterly, 2025-03-31) — Preferred Stock: 0.00
CZFS income_statement (quarterly, 2025-03-31) — Pretax Income: 9426000.00
CZFS cash_flow (quarterly, 2025-03-31) — Proceeds From Stock Option Exercised: 15000.00
CZFS income_statement (quarterly, 2025-03-31) — Professional Expense And Contract Services Expense: 517000.00
CZFS cash_flow (quarterly, 2025-03-31) — Purchase Of Investment: -23111000.00
CZFS cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: -585000.00
CZFS balance_sheet (quarterly, 2025-03-31) — Receivables: 10918000.00
CZFS income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 449000.00
CZFS cash_flow (quarterly, 2025-03-31) — Repayment Of Debt: 0.00
CZFS cash_flow (quarterly, 2025-03-31) — Repurchase Of Capital Stock: -57000.00
CZFS balance_sheet (quarterly, 2025-03-31) — Retained Earnings: 194709000.00
CZFS income_statement (quarterly, 2025-03-31) — Salaries And Wages: 10289000.00
CZFS cash_flow (quarterly, 2025-03-31) — Sale Of Business: 0.00
CZFS cash_flow (quarterly, 2025-03-31) — Sale Of Investment: 24173000.00
CZFS cash_flow (quarterly, 2025-03-31) — Sale Of PPE: 12000.00
CZFS income_statement (quarterly, 2025-03-31) — Selling General And Administration: 10739000.00
CZFS balance_sheet (quarterly, 2025-03-31) — Share Issued: 5259901.00
CZFS income_statement (quarterly, 2025-03-31) — Special Income Charges: 0.00
CZFS balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 308296000.00
CZFS balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 219831000.00
CZFS income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
CZFS income_statement (quarterly, 2025-03-31) — Tax Provision: 1805000.00
CZFS income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.19
CZFS balance_sheet (quarterly, 2025-03-31) — Total Assets: 3016338000.00
CZFS balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 610323000.00
CZFS balance_sheet (quarterly, 2025-03-31) — Total Debt: 302027000.00
CZFS balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 308296000.00
CZFS balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 2708042000.00
CZFS income_statement (quarterly, 2025-03-31) — Total Unusual Items: 0.00
CZFS income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: 0.00
CZFS balance_sheet (quarterly, 2025-03-31) — Treasury Shares Number: 452633.00
CZFS balance_sheet (quarterly, 2025-03-31) — Treasury Stock: 16392000.00
CZFS income_statement (quarterly, 2025-06-30) — +Total Revenue: 27313000.00
CZFS balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 2741000.00
CZFS balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 10603000.00
CZFS balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 147878000.00
CZFS income_statement (quarterly, 2025-06-30) — Amortization: 127000.00
CZFS income_statement (quarterly, 2025-06-30) — Amortization Of Intangibles Income Statement: 127000.00
CZFS cash_flow (quarterly, 2025-06-30) — Amortization Of Securities: 213000.00
CZFS balance_sheet (quarterly, 2025-06-30) — Available For Sale Securities: 1768000.00
CZFS income_statement (quarterly, 2025-06-30) — Basic Average Shares: 4797716.00
CZFS income_statement (quarterly, 2025-06-30) — Basic EPS: 1.76
CZFS cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 36786000.00
CZFS cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -495000.00
CZFS balance_sheet (quarterly, 2025-06-30) — Capital Stock: 5255000.00
CZFS balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 53304000.00
CZFS balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Federal Funds Sold: 53304000.00
CZFS cash_flow (quarterly, 2025-06-30) — Cash Dividends Paid: -2388000.00
CZFS cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: -63980000.00
CZFS cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: 70694000.00
CZFS cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: 5984000.00
CZFS cash_flow (quarterly, 2025-06-30) — Change In Account Payable: -402000.00
CZFS cash_flow (quarterly, 2025-06-30) — Change In Payable: -402000.00
CZFS cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: -402000.00
CZFS cash_flow (quarterly, 2025-06-30) — Change In Receivables: 316000.00
CZFS cash_flow (quarterly, 2025-06-30) — Change In Working Capital: -86000.00
CZFS cash_flow (quarterly, 2025-06-30) — Changes In Account Receivables: 316000.00
CZFS cash_flow (quarterly, 2025-06-30) — Changes In Cash: 12698000.00
CZFS balance_sheet (quarterly, 2025-06-30) — Common Stock: 5255000.00
CZFS cash_flow (quarterly, 2025-06-30) — Common Stock Dividend Paid: -2388000.00
CZFS balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 313653000.00
CZFS cash_flow (quarterly, 2025-06-30) — Common Stock Payments: -239000.00
CZFS cash_flow (quarterly, 2025-06-30) — Deferred Income Tax: 732000.00
CZFS cash_flow (quarterly, 2025-06-30) — Deferred Tax: 732000.00
CZFS cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 472000.00
CZFS income_statement (quarterly, 2025-06-30) — Depreciation Amortization Depletion Income Statement: 127000.00
CZFS cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 472000.00
CZFS income_statement (quarterly, 2025-06-30) — Depreciation And Amortization In Income Statement: 127000.00
CZFS balance_sheet (quarterly, 2025-06-30) — Derivative Product Liabilities: 4701000.00
CZFS income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 4800384.00
CZFS income_statement (quarterly, 2025-06-30) — Diluted EPS: 1.76
CZFS income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 8463000.00
CZFS cash_flow (quarterly, 2025-06-30) — End Cash Position: 49484000.00
CZFS cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: -63980000.00
CZFS cash_flow (quarterly, 2025-06-30) — Free Cash Flow: 5489000.00
CZFS cash_flow (quarterly, 2025-06-30) — Gain Loss On Investment Securities: -32000.00
CZFS cash_flow (quarterly, 2025-06-30) — Gain Loss On Sale Of Business: 0.00
CZFS income_statement (quarterly, 2025-06-30) — Gain On Sale Of Business: 0.00
CZFS income_statement (quarterly, 2025-06-30) — Gain On Sale Of Security: 32000.00
CZFS balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: -21026000.00
CZFS income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 10471000.00
CZFS balance_sheet (quarterly, 2025-06-30) — Goodwill: 85758000.00
CZFS balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 88288000.00
CZFS cash_flow (quarterly, 2025-06-30) — Income Tax Paid Supplemental Data: 2500000.00
CZFS income_statement (quarterly, 2025-06-30) — Insurance And Claims: 495000.00
CZFS income_statement (quarterly, 2025-06-30) — Interest Expense: 15101000.00
CZFS income_statement (quarterly, 2025-06-30) — Interest Income: 38340000.00
CZFS cash_flow (quarterly, 2025-06-30) — Interest Paid Supplemental Data: 15503000.00
CZFS balance_sheet (quarterly, 2025-06-30) — Invested Capital: 626872000.00
CZFS cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: 70694000.00
CZFS balance_sheet (quarterly, 2025-06-30) — Investments And Advances: 65217000.00
CZFS balance_sheet (quarterly, 2025-06-30) — Long Term Debt: 313219000.00
CZFS balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 313219000.00
CZFS cash_flow (quarterly, 2025-06-30) — Long Term Debt Payments: -10000000.00
CZFS cash_flow (quarterly, 2025-06-30) — Net Business Purchase And Sale: 0.00
CZFS cash_flow (quarterly, 2025-06-30) — Net Common Stock Issuance: -239000.00
CZFS balance_sheet (quarterly, 2025-06-30) — Net Debt: 259915000.00
CZFS income_statement (quarterly, 2025-06-30) — Net Income: 8463000.00
CZFS income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 8463000.00
CZFS income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 8463000.00
CZFS income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 8463000.00
CZFS income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 8463000.00
CZFS cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: 8463000.00
CZFS income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 8463000.00
CZFS income_statement (quarterly, 2025-06-30) — Net Interest Income: 23239000.00
CZFS cash_flow (quarterly, 2025-06-30) — Net Investment Purchase And Sale: -3607000.00
CZFS cash_flow (quarterly, 2025-06-30) — Net Issuance Payments Of Debt: 10822000.00
CZFS cash_flow (quarterly, 2025-06-30) — Net Long Term Debt Issuance: -10000000.00
CZFS cash_flow (quarterly, 2025-06-30) — Net Other Investing Changes: 273000.00
CZFS balance_sheet (quarterly, 2025-06-30) — Net PPE: 21776000.00
CZFS cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: -495000.00
CZFS cash_flow (quarterly, 2025-06-30) — Net Short Term Debt Issuance: 20822000.00
CZFS balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 225365000.00
CZFS income_statement (quarterly, 2025-06-30) — Normalized Income: 8463000.00
CZFS income_statement (quarterly, 2025-06-30) — Occupancy And Equipment: 1500000.00
CZFS cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: 5984000.00
CZFS cash_flow (quarterly, 2025-06-30) — Operating Gains Losses: -771000.00
CZFS income_statement (quarterly, 2025-06-30) — Operating Revenue: 27313000.00
CZFS balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 4807000.00
CZFS balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: -21026000.00
CZFS balance_sheet (quarterly, 2025-06-30) — Other Intangible Assets: 2530000.00
CZFS cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: -3789000.00
CZFS income_statement (quarterly, 2025-06-30) — Other Non Interest Expense: 3524000.00
CZFS balance_sheet (quarterly, 2025-06-30) — Other Short Term Investments: 63449000.00
CZFS balance_sheet (quarterly, 2025-06-30) — Payables: 2741000.00
CZFS balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 2741000.00
CZFS balance_sheet (quarterly, 2025-06-30) — Preferred Stock: 0.00
CZFS income_statement (quarterly, 2025-06-30) — Pretax Income: 10416000.00
CZFS cash_flow (quarterly, 2025-06-30) — Proceeds From Stock Option Exercised: 17000.00
CZFS income_statement (quarterly, 2025-06-30) — Professional Expense And Contract Services Expense: 525000.00
CZFS cash_flow (quarterly, 2025-06-30) — Purchase Of Investment: -29317000.00
CZFS cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: -495000.00
CZFS balance_sheet (quarterly, 2025-06-30) — Receivables: 10603000.00
CZFS income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 472000.00
CZFS cash_flow (quarterly, 2025-06-30) — Repayment Of Debt: -10000000.00
CZFS cash_flow (quarterly, 2025-06-30) — Repurchase Of Capital Stock: -239000.00
CZFS balance_sheet (quarterly, 2025-06-30) — Retained Earnings: 197940000.00
CZFS income_statement (quarterly, 2025-06-30) — Salaries And Wages: 9976000.00
CZFS cash_flow (quarterly, 2025-06-30) — Sale Of Business: 0.00
CZFS cash_flow (quarterly, 2025-06-30) — Sale Of Investment: 25710000.00
CZFS cash_flow (quarterly, 2025-06-30) — Sale Of PPE: 0.00
CZFS income_statement (quarterly, 2025-06-30) — Selling General And Administration: 10471000.00
CZFS balance_sheet (quarterly, 2025-06-30) — Share Issued: 5255190.00
CZFS income_statement (quarterly, 2025-06-30) — Special Income Charges: 0.00
CZFS balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 313653000.00
CZFS balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 225365000.00
CZFS income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
CZFS income_statement (quarterly, 2025-06-30) — Tax Provision: 1953000.00
CZFS income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.19
CZFS balance_sheet (quarterly, 2025-06-30) — Total Assets: 2967274000.00
CZFS balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 626872000.00
CZFS balance_sheet (quarterly, 2025-06-30) — Total Debt: 313219000.00
CZFS balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 313653000.00
CZFS balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 2653621000.00
CZFS income_statement (quarterly, 2025-06-30) — Total Unusual Items: 0.00
CZFS income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: 0.00
CZFS balance_sheet (quarterly, 2025-06-30) — Treasury Shares Number: 448190.00
CZFS balance_sheet (quarterly, 2025-06-30) — Treasury Stock: 16394000.00
CZFS income_statement (quarterly, 2025-09-30) — +Total Revenue: 28994000.00
CZFS balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 3754000.00
CZFS balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 11412000.00
CZFS balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 147971000.00
CZFS income_statement (quarterly, 2025-09-30) — Amortization: 113000.00
CZFS income_statement (quarterly, 2025-09-30) — Amortization Of Intangibles Income Statement: 113000.00
CZFS cash_flow (quarterly, 2025-09-30) — Amortization Of Securities: 117000.00
CZFS balance_sheet (quarterly, 2025-09-30) — Available For Sale Securities: 1803000.00
CZFS income_statement (quarterly, 2025-09-30) — Basic Average Shares: 4796946.00
CZFS income_statement (quarterly, 2025-09-30) — Basic EPS: 2.09
CZFS cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 49484000.00
CZFS cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -145000.00
CZFS balance_sheet (quarterly, 2025-09-30) — Capital Stock: 5255000.00
CZFS balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 34895000.00
CZFS balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Federal Funds Sold: 34895000.00
CZFS cash_flow (quarterly, 2025-09-30) — Cash Dividends Paid: -2403000.00
CZFS cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: 82259000.00
CZFS cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: -103543000.00
CZFS cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: 2875000.00
CZFS cash_flow (quarterly, 2025-09-30) — Change In Account Payable: 1013000.00
CZFS cash_flow (quarterly, 2025-09-30) — Change In Payable: 1013000.00
CZFS cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: 1013000.00
CZFS cash_flow (quarterly, 2025-09-30) — Change In Receivables: -809000.00
CZFS cash_flow (quarterly, 2025-09-30) — Change In Working Capital: 204000.00
CZFS cash_flow (quarterly, 2025-09-30) — Changes In Account Receivables: -809000.00
CZFS cash_flow (quarterly, 2025-09-30) — Changes In Cash: -18409000.00
CZFS balance_sheet (quarterly, 2025-09-30) — Common Stock: 5255000.00
CZFS cash_flow (quarterly, 2025-09-30) — Common Stock Dividend Paid: -2403000.00
CZFS balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 327682000.00
CZFS cash_flow (quarterly, 2025-09-30) — Common Stock Payments: -77000.00
CZFS cash_flow (quarterly, 2025-09-30) — Deferred Income Tax: -76000.00
CZFS cash_flow (quarterly, 2025-09-30) — Deferred Tax: -76000.00
CZFS cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 493000.00
CZFS income_statement (quarterly, 2025-09-30) — Depreciation Amortization Depletion Income Statement: 113000.00
CZFS cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 493000.00
CZFS income_statement (quarterly, 2025-09-30) — Depreciation And Amortization In Income Statement: 113000.00
CZFS balance_sheet (quarterly, 2025-09-30) — Derivative Product Liabilities: 4332000.00
CZFS income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 4798051.00
CZFS income_statement (quarterly, 2025-09-30) — Diluted EPS: 2.09
CZFS income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 10005000.00
CZFS cash_flow (quarterly, 2025-09-30) — End Cash Position: 31075000.00
CZFS cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: 82259000.00
CZFS cash_flow (quarterly, 2025-09-30) — Free Cash Flow: 2730000.00
CZFS cash_flow (quarterly, 2025-09-30) — Gain Loss On Investment Securities: -35000.00
CZFS cash_flow (quarterly, 2025-09-30) — Gain Loss On Sale Of Business: 0.00
CZFS income_statement (quarterly, 2025-09-30) — Gain On Sale Of Business: 0.00
CZFS income_statement (quarterly, 2025-09-30) — Gain On Sale Of Security: 34000.00
CZFS balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: -14650000.00